Search research articles
Contact Us
Filters
Showing results (111-120 of 134) with videos related to
Page
of 14
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 15, 2025
Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 years
Christopher G Bunick, Alan D Irvine, Jonathan I Silverberg, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 1, 2023
Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial
Emma Guttman-Yassky, Jonathan I Silverberg, Diamant Thaçi, et al.
The Journal of Allergy and Clinical Immunology
|
December 2, 2019
Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial
Emma Guttman-Yassky, Diamant Thaçi, Aileen L Pangan, et al.
Journal of Natural Products
|
November 17, 2020
Phytotoxic Neocassane Diterpenes from <i>Eragrostis plana</i>
Ana Paula P Klein Hendges, Elaine Fernanda Dos Santos, Sirlei D Teixeira, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 5, 2023
Real-world clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study
Kilian Eyerich, Melinda J Gooderham, Juan Francisco Silvestre, et al.
Dermatology and Therapy
|
June 2, 2025
Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis
Eric L Simpson, Jonathan I Silverberg, Vimal H Prajapati, et al.
American Journal of Clinical Dermatology
|
March 26, 2024
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)
Jonathan I Silverberg, Melinda J Gooderham, Amy S Paller, et al.
Transplantation Proceedings
|
October 3, 2012
Atenolol to treat intestinal ischemia and reperfusion in rats
V F Campos, R Miranda-Ferreira, N S A Taha, et al.
Plos One
|
February 22, 2021
Decadal (2006-2018) dynamics of Southwestern Atlantic's largest turbid zone reefs
Carolina D Teixeira, Pamela M Chiroque-Solano, Felipe V Ribeiro, et al.
Biochemistry
|
April 26, 2024
Monomeric Esterase: Insights into Cooperative Behavior, Hysteresis/Allokairy
Tania Churasacari Vinces, Anacleto Silva de Souza, Cecília F Carvalho, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 134) with videos related to
Sort By:
Page
of 14
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 15, 2025
Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 years
Christopher G Bunick, Alan D Irvine, Jonathan I Silverberg, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 1, 2023
Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial
Emma Guttman-Yassky, Jonathan I Silverberg, Diamant Thaçi, et al.
The Journal of Allergy and Clinical Immunology
|
December 2, 2019
Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial
Emma Guttman-Yassky, Diamant Thaçi, Aileen L Pangan, et al.
Journal of Natural Products
|
November 17, 2020
Phytotoxic Neocassane Diterpenes from <i>Eragrostis plana</i>
Ana Paula P Klein Hendges, Elaine Fernanda Dos Santos, Sirlei D Teixeira, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 5, 2023
Real-world clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study
Kilian Eyerich, Melinda J Gooderham, Juan Francisco Silvestre, et al.
Dermatology and Therapy
|
June 2, 2025
Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis
Eric L Simpson, Jonathan I Silverberg, Vimal H Prajapati, et al.
American Journal of Clinical Dermatology
|
March 26, 2024
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)
Jonathan I Silverberg, Melinda J Gooderham, Amy S Paller, et al.
Transplantation Proceedings
|
October 3, 2012
Atenolol to treat intestinal ischemia and reperfusion in rats
V F Campos, R Miranda-Ferreira, N S A Taha, et al.
Plos One
|
February 22, 2021
Decadal (2006-2018) dynamics of Southwestern Atlantic's largest turbid zone reefs
Carolina D Teixeira, Pamela M Chiroque-Solano, Felipe V Ribeiro, et al.
Biochemistry
|
April 26, 2024
Monomeric Esterase: Insights into Cooperative Behavior, Hysteresis/Allokairy
Tania Churasacari Vinces, Anacleto Silva de Souza, Cecília F Carvalho, et al.
Page
of 14